Real-time funding, M&A, exec moves & hiring — the signals that move deals
More real-time opportunities that match your ICP — every funding, M&A, and exec move the moment it breaks, with the verified contacts to reach out first.
North GyeongsangNorth GyeongsangBiotechnologyHealth CareMedicalBiotechnologyHealth CareMedical DeviceHealth Diagnostics
Description
Cytogen has announced its merger with subsidiary GenomeCare to create a unified business entity focused on precision medical solutions. This strategic move is aimed at combining Cytogen's CTC technology with GenomeCare's reproductive diagnostics capabilities. The merger is expected to strengthen their market presence and enhance profitability through integrated services. CEO Ahn Ji-hoon highlighted the importance of this merger in pursuing long-term growth and stability.
Company Information
Company
Cytogen
Location
North Gyeongsang, South Korea
About
Cytogen is a precision medical company specializing in circulatory tumor cells (CTC). It focuses on rare cell separation and analysis technology to support cancer precision diagnosis and treatment. The company is also expanding into reproductive medical solutions and genetic testing. Cytogen aims to combine innovative technologies for comprehensive medical services.
North Gyeongsang